Introduction {#s1}
============

*Aeromonas* species are waterborne, Gram-negative, oxidase-positive, rod-shaped bacteria that are ubiquitous in water. This includes chlorinated drinking water, as the bacteria can grow and survive in biofilms in the water distribution systems [@pone.0030070-Sen1]. The prevalence of *Aeromonas* species in the aquatic environment has been recognized as a potential health risk, and some countries have adopted aeromonad counts as an additional indicator of water quality [@pone.0030070-Borchardt1].

The most common clinical manifestations of *Aeromonas* infections are diarrhea, bacteremia and localized soft-tissue infections [@pone.0030070-Figueras1]. Patients may acquire *Aeromonas* infections both in community and hospital settings [@pone.0030070-Figueras1]--[@pone.0030070-Anaissie1]. Both immunocompetent and immunocompromised patients are susceptible to *Aeromonas* infections [@pone.0030070-Figueras1], [@pone.0030070-Janda1]. The gastrointestinal tract is by far the most common anatomic site from which aeromonads are recovered [@pone.0030070-Figueras1], [@pone.0030070-Janda1]. *Aeromonas* have been isolated from children with acute diarrhea and from adults with traveler\'s diarrhea [@pone.0030070-Figueras1], [@pone.0030070-Janda1]--[@pone.0030070-Burke1]. The following species are frequently associated with diarrhea in humans: *A. hydrophila*, *A. veronii* bv. *sobria* and *A. cavia* [@pone.0030070-Figueras1], [@pone.0030070-Janda1], [@pone.0030070-Ormen1], [@pone.0030070-Agarwal1], [@pone.0030070-Janda2].

The mechanism of *Aeromonas* pathogenesis is complex and not well understood. *Aeromonas* virulence is considered to be multifactorial. The virulence factors that were associated with *Aeromonas* pathogenicity are: cytotoxic enterotoxin, haemolysins, proteases \[serine protease (*aspA*), elastase (*ahpB*)\], lipases (*pla* and *plc*, *sat*), DNAses and adhesins \[type IV pili and polar flagella (*flaA* and *flaB*)\] [@pone.0030070-Sen1], [@pone.0030070-Janda1], [@pone.0030070-Ormen1], [@pone.0030070-Agarwal1], [@pone.0030070-Kingombe1], [@pone.0030070-AguileraArreola1]. Several of these virulence factors have been identified in strains isolated from water [@pone.0030070-Sen1]. In addition, genes for a type III secretion system (TTSS) were identified in this genus [@pone.0030070-Yu1], [@pone.0030070-Chacn1]. TTSS has a role in delivering toxins directly into the host cell and in inducing apoptosis [@pone.0030070-Yu1], [@pone.0030070-Chacn1].

In Israel, diarrhea patients are tested routinely by clinical laboratories for the presence of several bacterial pathogens, such as: *Campylobacter* spp., *Shigella* spp. and *Salmonella* spp., but not for *Aeromonas*. The aim of this research was to study the prevalence and virulence potential of *Aeromonas* spp. in diarrheal stools in Israel.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

N/A. The data was analyzed anonymously.

We have applied to the ethics committee at Carmel Hospital, Clalit Health Services, Haifa, Israel, and the committee stated that such a research does not fall under the scope of the Helsinki Committee.

*Aeromonas* Prevalence in Diarrheal Stools {#s2b}
------------------------------------------

The presence of *Aeromonas* was monitored in fecal specimens from diarrheal patients submitted to the Microbiology Laboratory of Clalit Health Services in Haifa. This Laboratory provides services to a wide range of population, from the district of Haifa and West Galilee in Israel (this is a community health service, not a hospital). The surveillance was conducted between April 13 and September 15, 2010 (five months). All specimens were checked routinely for the following enteropathogens: *Shigella*, *Salmonella* and *Campylobacter* spp. were isolated and identified by conventional methods [@pone.0030070-Murray1]; *Rotavirus* was detected by an antigen detection method (Novamed, Israel); parasites were studied according to methods described in Garcia and Isenberg [@pone.0030070-Garcia1]. For the isolation of *Aeromonas* spp. the fecal specimens were either enriched in alkaline peptone water (APW) containing peptone (1%, wt/vol) and NaCl (1%, wt/vol) pH 8.5, or directly streaked on a selective m-Aeromonas agar base (Havelaar Biolife, Milano, Italy). In the case of enrichment, the tubes were incubated at 37°C without shaking for 6--18 h, and then streaked on m-Aeromonas selective agar. The agar plates were incubated overnight at 37°C. Colonies that were morphologically suspected as *Aeromonas* (yellow, smooth and rounded) were subcultured onto LB agar (Himedia, India), and then tested for oxidase (1% tetramethyl-phenylenediamine, Sigma). The identity of the isolates with positive results was further verified by *Aeromonas* genus specific PCR assay in accordance with Kong et al. (1999) [@pone.0030070-Kong1]. Reddy Mix PCR master mixture (ABgene, Epsom, UK) was used for the DNA amplification. All the isolates that were found to belong to the *Aeromonas* genus were maintained in LB with 30% glycerol (−80°C).

*Aeromonas* isolates were further identified by amplifying and sequencing the housekeeping gene *rpoD*, encoding *σ* ^70^ factor, which is one of the sigma factors that confer promoter-specific transcription initiation on RNA polymerase [@pone.0030070-Soler1]. The PCR products were sequenced by MCLAB (San Francisco, CA). Newly determined sequences were compared to those available in the GenBank database, using the standard nucleotide--nucleotide BLAST program (BLASTN; <http://www.ncbi.nlm.nih.gov>), to ascertain their closest relatives. The sequences were submitted to the GenBank database under accession numbers JF738005--JF738021. A phylogenetic tree was generated using the neighbor-joining method with NJPlot (MEGA 4.1) based on alignments from CLUSTAL W.

Virulence Factors and Antimicrobial Susceptibility {#s2c}
--------------------------------------------------

The presence of the following genes encoding virulence factors was determined in all *Aeromonas* isolates: cytotoxic enterotoxin (*act*)/aerolysin (*aerA*)/haemolysin (*hlyA*) by using one set of primers AHCF1/AHCR1 [@pone.0030070-Kingombe1]; *alt* and *ast* genes for cytotonic enterotoxins; *ahyB* gene for elastase; *pla*/*lipH3*/*apl-1*/*lip* genes for phospholipase; and *fla* gene for flagellin [@pone.0030070-Sen1]. The presence of the genes *act*/*aerA*/*hlyA* and *ast*; *fla* and *alt*; *ahyB* and *pla*/*lipH3*/*apl-1*/*lip* was tested simultaneously in the same reaction mixture, in accordance with Sen and Rodgers (2004) [@pone.0030070-Sen1]. The presence of genes encoding the components of the type III secretion system, *ascV*, *ascF-ascG* [@pone.0030070-Chacn1], type III secretion dependent ADP-ribosylating toxins, *aexT* and *aexU* [@pone.0030070-Silver1], and of *lafA* gene encoding a lateral flagella [@pone.0030070-AguileraArreola1] was determined as well.

The disk diffusion antimicrobial susceptibility tests were performed by a standardized method [@pone.0030070-Miller1], [@pone.0030070-Jorgensen1]. All disks were purchased from OXOID (UK).

Results {#s3}
=======

*Aeromonas* Prevalence in Diarrheal Stools {#s3a}
------------------------------------------

A total of 1,033 stool specimens from patients suffering from diarrhea were monitored for the presence of *Aeromonas* during a five month period between April 13 and September 15, 2010. Seventeen patients (∼2%) tested positive for *Aeromonas* species which included 11 (65%) *A. caviae*, five (29%) *A. veronii*, and one strain, (H53AQ1). This strain showed the highest *rpoD* gene similarity (96%) to the deposited sequence of the type strain of *A. taiwanensis*, and clustered with this species in the phylogenetic tree ([Figure 1](#pone-0030070-g001){ref-type="fig"}).

![Phylogenetic tree of *Aeromonas* isolates recovered from diarrhea patients.\
The tree shows the relationships based on partial sequences of *rpoD* gene of type strains of *Aeromonas* species and the isolates from the current study. The sequence alignments were performed using the CLUSTAL W program, and the tree was generated using the neighbor--joining method with Kimura 2 parameter distances in MEGA 4.1 software. Bootstrap values (from 1,000 replicates) greater than 50% are shown at the branch points. The bar indicates 2% sequence divergence.](pone.0030070.g001){#pone-0030070-g001}

The specimens of the diarrhea patients were also checked for other enteropathogenes. The results revealed that pathogenic bacteria, *Rotavirus* and parasites were recovered from about 15% (155 of 1033) of the diarrhea patients. The prevalence of the detected enterophathogenes was; *Campylobacter* sp. 5.2%, *Shigella* 3.3%, *Salmonella enterica* 2%, *Aeromonas* spp. 2%, *Rotavirus* 0.4%, *Giardia lamblia* 2.3%, and *Cryptosporidium parvum* 0.15%. Mixed infections were found in four patients that were positive for *Aeromonas* as well as for other known enteropathogens ([Table S1](#pone.0030070.s001){ref-type="supplementary-material"}).

Virulence Factors and Antimicrobial Susceptibility {#s3b}
--------------------------------------------------

All *Aeromonas* isolates were screened for the presence of virulence genes ([Table 1](#pone-0030070-t001){ref-type="table"}). The most prevalent genes were *ahyB* (88%) and *pla*/*lipH3*/*apl-1*/*lip* (71%). The two types of flagella that were screened (polar and lateral) were quite prevalent as well (65% and 41%, respectively). In every strain that was positive for the genes encoding the TTSS, a gene for the effector *aexU* was present as well. The *ast* gene was found only in one isolate (H65AT3), which was identified as *A. veronii*. The virulence genotypes were found in different combinations: three isolates (18%) possessed five different genes, four (24%) possessed three or four different genes and two (12%) possessed two different genes ([Table 1](#pone-0030070-t001){ref-type="table"}).

10.1371/journal.pone.0030070.t001

###### Prevalence of virulence genes in *Aeromonas* isolates from diarrheal patients.

![](pone.0030070.t001){#pone-0030070-t001-1}

  Isolatename    Virulence genes                                               
  ------------- ----------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  H3TK1                \+          \+   −    −    −    \+   −    −    −    −    −
  H15AI+1              \+          \+   \+   −    \+   −    −    −    −    −    −
  H17AD1                −          −    \+   −    \+   \+   −    −    −    \+   −
  H22AJ4               \+          \+   −    −    −    −    −    −    −    −    −
  H22AG8                −          −    \+   −    −    \+   −    \+   \+   −    \+
  H23AM+2              \+          \+   \+   −    −    \+   \+   −    −    −    −
  H30AD+5              \+          \+   −    −    −    −    \+   −    −    −    −
  H33AJ+7              \+          −    −    −    −    \+   −    −    −    −    \+
  H34AA+4              \+          \+   \+   −    −    \+   \+   −    −    −    −
  H35AG+1              \+          \+   −    −    −    \+   \+   −    −    −    −
  H39AA+3              \+          \+   −    −    \+   −    −    −    −    −    \+
  H45AF+12             \+          \+   −    −    −    \+   \+   −    −    −    \+
  H45AK+3              \+          \+   −    −    −    \+   −    −    −    −    −
  H50AI2               \+          \+   \+   −    −    \+   −    \+   −    −    \+
  H53AQ1               \+          −    −    −    −    \+   −    −    \+   −    \+
  H65AT3                −          \+   −    \+   −    −    \+   −    −    −    −
  H67AJ5               \+          \+   −    −    −    −    \+   −    −    −    \+

For more details on the isolates and on the patients see [Table S1](#pone.0030070.s001){ref-type="supplementary-material"}.

The susceptibility of *Aeromonas* isolates was evaluated against 15 antimicrobial agents. All isolates were susceptible to amikacin, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin and chloramphenicol; however, they varied in their susceptibility to other antimicrobial agents ([Table 2](#pone-0030070-t002){ref-type="table"}). The three *Aeromonas* species displayed the same antibiotic sensitivity patterns.

10.1371/journal.pone.0030070.t002

###### Susceptibility of *Aeromonas* isolates to antimicrobial agents.

![](pone.0030070.t002){#pone-0030070-t002-2}

  Antimicrobial agent                               Number (%) of strains  
  ------------------------------------- ---------- ----------------------- --------
  amikacin (11)                          11 (100)            \-               \-
  cefotaxime (11)                        11 (100)            \-               \-
  ceftazidime (11)                       11 (100)            \-               \-
  ceftriaxone (E test) (11)              11 (100)            \-               \-
  ciprofloxacin (11)                     11 (100)            \-               \-
  chloramphenicol (11)                   11 (100)            \-               \-
  gentamicin (11)                        10 (91)             \-             1 (9)
  piperacillin--tazobactam (11)          10 (91)             \-             1 (9)
  trimethoprim--sulfamethoxazole (11)    10 (91)             \-             1 (9)
  imipenem (also meropenem) (11)          8 (73)             \-             3 (27)
  cefoxitin (10)                          7 (70)           2 (20)           1 (10)
  nalidixic acid (11)                     7 (64)             \-             4 (36)
  tetracycline (11)                       6 (55)             \-             5 (45)
  amoxicillin+clavulanic acid (11)        3 (27)           3 (27)           5 (46)
  cephalotin (10)                         2 (20)             \-             8 (80)

Most of the identified strains were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics.

Discussion {#s4}
==========

Despite the existence of detailed case reports and epidemiological case control investigations, the role of *Aeromonas* as the etiological agent of bacterial diarrhea has been questioned and debated several times [@pone.0030070-Figueras1], [@pone.0030070-Janda1], [@pone.0030070-Janda2], . Figueras et al. [@pone.0030070-Figueras2] rebutted arguments provided by several authors against considering *Aeromonas* a true enteropathogenic bacterium one by one. Today it is well accepted that if *Aeromonas* can cause different infections like cellulitis, meningitis, pneumonia, wound infections and more in healthy humans, it can also have the capacity to produce diarrhea [@pone.0030070-Figueras1], [@pone.0030070-Janda1], [@pone.0030070-Figueras2].

In several reported studies throughout the world, *Aeromonas* species have been isolated at a rate of 0.6 to 7.2% in patients with diarrhea, predominantly in infants and children [@pone.0030070-Borchardt1], [@pone.0030070-Moyer1]. In the current study, *Aeromonas* positive patients ranged in age and only two out of 17 isolates were taken from children ([Table S1](#pone.0030070.s001){ref-type="supplementary-material"}). The current study relied on a limited amount of strains as it was performed only during a period of five months; however, the *Aeromonas* isolation rate amounted to about 2%, which is similar to the rate obtained in other studies performed in other countries \[3,6 and references therein\], as well as in Israel in 1990 [@pone.0030070-Golik1]. In a recent study performed by Pablos et al. [@pone.0030070-Pablos1] in León (Spain) they found a frequency of *Aeromonas* of 4% (32 positive patients of the 800 investigated), mainly associated with infant or pediatric patients (68.8%). Furthermore they found mixed infections with other pathogens in 12 patients [@pone.0030070-Pablos1]. In our study, only two of the patients were infants (12%), and all four patients that had mixed infections were adults ([Table S1](#pone.0030070.s001){ref-type="supplementary-material"}).

In mixed infections, *Aeromonas* may be transient colonizers lacking a causal relationship with a disease, but in some cases, multiple pathogens may act synergistically to produce diarrhea [@pone.0030070-Albert1]. *Aeromonas* species are carried asymptomatically by some individuals [@pone.0030070-Figueras1], [@pone.0030070-Janda1] as occurs with other recognized enteropathogens like *Salmonella*. However, a study that was performed in 1990 in Israel compared the prevalence of *Aeromonas* in the stools obtained from 932 adult patients with acute diarrhea (recovered between 1986 and 1987) to 500 stools from asymptomatic controls. They found an *Aeromonas* prevalence of about 2% in the diarrhea cases, which conforms to our study. But no *Aeromonas* were detected in the controls [@pone.0030070-Golik1]. This seems to indicate a clear association of *Aeromonas* with diarrhea cases in Israel, as we found in our study.

Among the recognized *Aeromonas* species, *A. veronii* bv. *sobria*, *A. caviae* and *A. hydrophila* are more frequently associated with diarrhea in humans, representing 85% of clinical isolates [@pone.0030070-Janda2]. Interestingly, none of the identified strains in the current study belonged to *A. hydrophila*. This is in agreement with the false importance attributed to this species on the basis of phenotypic identifications [@pone.0030070-Figueras1], [@pone.0030070-Figueras2]. In the current study, *A. caviae* was the predominating species (65%, 11/17), followed by *A. veronii* that was isolated from five patients (29%). One patient carried a strain that was identified as *A. taiwanensis* ([Figure 1](#pone-0030070-g001){ref-type="fig"}). All the strains were identified using the *rpoD* gene sequencing method. *Aeromonas* identification on the basis of *rpoD* gene sequencing is considered to be much more accurate than 16S rRNA gene sequencing or biochemical identification methods. The fact that many studies found *A. hydrophila* a major species to cause diarrhea (among *Aeromonas* species) may be due to limitations in the identification methods that were used in those studies [@pone.0030070-Figueras1], [@pone.0030070-Figueras2].

The current study provides the first clinical record of *A. taiwanensis* as a diarrheal causative since this species was identified [@pone.0030070-Alperi1]. So far, the only available strain (the type strain) was recovered from an infected burn wound of a 40 years old male [@pone.0030070-Alperi1] and in the current study the strain was isolated from feces of a 35 years old diarrheal female patient.

The clinical manifestations of *Aeromonas* associated gastroenteritis can range from mild self-limiting watery diarrhea to a more severe and invasive dysenteric form. Chronic diarrhea episodes and isolated cases of a cholera-like illness have also been described [@pone.0030070-Janda2]. The bacterial flagella are thought to play an important role in pathogenicity. *Aeromonas* produces two types of flagella: a constitutively expressed polar flagellum (*fla*) and multiple inducible lateral flagella (*laf*). Both types play a role in the attachment of the bacteria to the gastrointestinal epithelium, biofilm formation and long-term colonization [@pone.0030070-Janda1]. Both types of flagella (*fla* and *lafA*) were common among the *Aeromonas* isolates from the patients in the current study ([Table 1](#pone-0030070-t001){ref-type="table"}). The occurrence of genes encoding hemolytic, cytotonic, cytotoxic, and enterotoxic activities (*aerA*, *hlyA*, *alt*, *ast*, *act*) may contribute to diarrheal-related virulence [@pone.0030070-Janda1], [@pone.0030070-Alperi1], [@pone.0030070-Heuzenroeder1]. In the present study, 35% of the *Aeromonas* isolates possessed the *act/aerA/hlyA* gene. The most prevalent virulence-associated genes in the isolates from our study were *ahpB* for elastase (88%) and *pla/lip/lipH3/apl-1* for lipase (71%) ([Table 1](#pone-0030070-t001){ref-type="table"}). These genes may be essential for the ability of the bacterium to adhere and invade the intestinal mucosa [@pone.0030070-Sen1].

Type III secretion system (TTSS) plays crucial roles in host-pathogen interactions [@pone.0030070-Yu1], [@pone.0030070-Chacn1]. One of the best-described toxins that are translocated via a TTSS is the ADP-ribosylating toxin, AexT. This toxin was found to be more common among the environmental, rather than the clinical *Aeromonas* strains [@pone.0030070-AguileraArreola1]. In our study, the gene for this toxin was detected only in one strain. Recently, a novel type-three-secretion-dependent effector, AexU, was discovered in *Aeromonas*. AexU is an ADP-ribosylating toxin and is required for virulence of *Aeromonas hydrophila* in mice [@pone.0030070-Silver1]. The gene for this toxin was quite prevalent among the strains in our study (41%). The prevalence of the genes encoding TTSS apparatus (12%) was lower than the *aexU* gene prevalence (41%). The TTSS is probably underrepresented, as may happen in PCR based studies. Nevertheless, the presence of *aexU* gene strengthens the case of *Aeromonas* being recognized as a stronger pathogen.

In another study that surveyed the distribution of virulence associated genes among *Aeromonas* species from human stool specimens in Spain, it was found that *alt*, *ast*, *laf*, *aerA*, and *hlyA* genes were present in 72, 19, 3, 25, and 28% of the strains, respectively. None of the strains harbored *ascF -- G* [@pone.0030070-Pablos1]. In clinical diarrheic isolates of *A. hydrophila* in Spain the distribution of associated virulence genes was different: *alt* -- 82%, *ast* -- 96%, *laf* -- 77%, *aexT* -- 5%, *ascV* -- 5% [@pone.0030070-AguileraArreola1].

*Aeromonas* species are known to be intrinsically susceptible to all antibiotics active against non-fastidious Gram-negative bacilli, except for many beta--lactams, due to the production of multiple inducible, chromosomally encoded β--lactamases [@pone.0030070-Jones1]. In our study, most strains (80%) were resistant to cephalotin and partially resistant to amoxicillin combined with clavulanic acid (46%) ([Table 2](#pone-0030070-t002){ref-type="table"}). All strains were susceptible to third-generation cephalosporin antibiotics (cefotaxime, ceftazidime, ceftriaxone), second-generation fluoroquinolone antibiotics -- ciprofloxacin, aminoglycoside antibiotic -- amikacin, and to chloramphenicol.

Recently, it was found that the egg masses of chironomids, non-biting midges, (*Diptera; Chironomidae*) serve as a natural reservoir for *Aeromonas* pathogenic species [@pone.0030070-Senderovich1], [@pone.0030070-Figueras3] as well as for *Vibrio cholerae* [@pone.0030070-Broza1]. Chironomid infestations in drinking water supply systems are an existing problem in Israel [@pone.0030070-Halpern1] and worldwide [@pone.0030070-Sun1]. Chironomids may disseminate pathogenic species of *Aeromonas* between drinking water reservoirs, as was suggested for *V. cholerae* [@pone.0030070-Broza2].

The source of *Aeromonas* in diarrheal patients was not investigated in the current study. In order to investigate the route of transmission of *Aeromonas* pathogenic strains an extensive study on strains from various origins should be performed. Chironomid egg masses in drinking water ponds and tap waters should be screened for *Aeromonas* isolates and compared with isolates from diarrheal patients.

*Aeromonas* infections are self--limiting, but their diagnosis may be crucial in young children, old and immunocompromised patients. We conclude that *Aeromonas* may be a causative agent of diarrhea in patients in Israel and therefore should be included in routine bacteriological screenings.
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